I agree, Murph, that no one wants a RS; that would also hold true for JJ I believe. Personally, just a guess, but I think he has a good indication what is coming for the company, and based on that, he is communicating to the investment community and shareholders that this company has significant growth and consequent sp upside for the year. The info posted yesterday by Edva agrees with this line of thinking. I know I won't be selling soon!
AETHLON MEDICAL- We fully expect this to be a company changing year for AEMD. The results of the CTE study originated by Boston University are expected at some point this month. Previously this often fatal disease was only able to be observed upon autopsy. For athletes and soldiers the world over early DIAGNOSIS could mean the difference between a life of misery and challenge or just a life. Recently, Aethlon’s Hemopurifier was approved to be used for an FDA study on Ebola patients at 10 medical centers around the country. There are so many different kinds of catalysts that this company has that they are too many to mention in this brief entry but you can look to some of my past posts or simply try to consider the conversations with health officials that Aethlon must be having or perhaps even companies interested in furthering their efforts. These kind of partnerships can obviously take many forms. As far as price action I would not be at all surprised if AEMD takes out the recent highs at some point during the first quarter of this year, maybe even this month.
News 
Market Data 
Discover 
